Article · 28 Mar 2025
Conference abstract
Immune complex as vaccines against Tuberculosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immune complex (IC) is formed as a result of specific reaction between antigen and its specific antibody. Following the formation of these antigen-antibody complexes a cascade of events like opsonization, complement activation, antigen presentation occurs inside the host system. For many decades, either antigen or antibodies are being used as vaccine candidates. In the event of acquiring this kind of artificial immunization, involvement of humoral immunity is essential for memory response. But before that, the administered antigen has to be captured by cell mediated immune surveillance and has to be presented by APCs and this is a long time process. This kind of delay is avoided when preformed IC is administered, which directly binds with APCs through antibody mediated binding. Also Fc region of immunoglobulin from IC acts as molecular adjuvants and thereby enhances immunization position of IC. In a study by Wen et al., (1999) excess Hepatitis B surface antigen (HBsAg) complexed with human anti-HBs immunoglobulin was used as a therapeutic vaccine to treat chronic hepatitis B patients. Promising results were obtained and the studies indicated that IC induced enhanced immune responses by increasing the uptake of HBsAg through the Fc receptors on the antigen-presenting cells and modulating the HBsAg processing and presentation. In our preliminary study using preformed IC of tuberculosis, we observed a protective response in animals when administered with ICs of antigen excess. This showed a significant response when compared to the animals injected with antibody excess or without any ICs. Hence IC in future could be considered as efficient vaccine candidates for Tuberculosis.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Rapid communication · 2012
Evaluation and Identification of in vitro Cellular Immune Response to Culture Filtrate Antigens of M. tuberculosis Culture. Implications for Vaccine Design
Conference abstract
Increased efficacy of BCG vaccines against experimental tuberculosis through genetic engineering of Th1 driving and immune-modulatory peptide epitopes
Conference abstract
The development of tuberculosis subunit vaccine EAMMH and regulation of vaccine induced immune memory by rapamycin
Research article · 2017
Immune Response Modifying Effects of Bee Venom Protein [Melittin]/Autoclaved L. donovani complex in CD1 Mice: The Search for New Vaccine Adjuvants
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advancing Immune-Based Disease Management through Therapeutic Vaccines
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Shakila H”
- BylineArticles whose byline prints “Sam Ebenezer”
- BylineArticles whose byline prints “Gupta U D”
